Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Bioxytran, Inc. (BIXT) had Stock-Based Compensation of $0.07M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$0.04M |
|
-- |
|
-- |
|
$0.22M |
|
$-0.22M |
|
$0.26M |
|
$0.04M |
|
$0.04M |
|
$0.04M |
|
$0.04M |
|
$0.04M |
|
$0.04M |
|
$-0.22M |
|
$-0.22M |
|
88.84M |
|
88.84M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.00M |
|
-- |
|
$0.14M |
|
$0.15M |
|
$2.78M |
|
-- |
|
-- |
|
$2.78M |
|
$-2.68M |
|
$-2.78M |
|
$-2.64M |
|
88.99M |
|
| Cash Flow Statement Financials | |
$-0.25M |
|
$-0.02M |
|
$0.26M |
|
$0.01M |
|
$0.00M |
|
$-0.00M |
|
|
Stock-Based Compensation |
$0.07M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1.32% |
|
-1.27% |
|
24.02% |
|
-1.34% |
|
$-0.03 |
|
$-0.00 |
|
$-0.00 |
|